These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36635138)

  • 21. Induction of potential protective immunity against enterotoxemia in calves by single or multiple recombinant Clostridium perfringens toxoids.
    Jiang Z; De Y; Chang J; Wang F; Yu L
    Microbiol Immunol; 2014 Nov; 58(11):621-7. PubMed ID: 25197030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterotoxemia produced by lambda toxin-positive
    Acevedo HD; Schlesinger MS; Streitenberger N; Henderson E; Asin J; Beingesser J; Uzal FA
    J Vet Diagn Invest; 2023 Jul; 35(4):448-451. PubMed ID: 37212504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of plant-produced
    Mokoena T; Chakauya E; Crampton M; Weyers B; Tselanyane M; Tsekoa T; Chikwamba R
    Onderstepoort J Vet Res; 2017 Apr; 84(1):e1-e7. PubMed ID: 28470084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
    Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
    Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pore structure of Clostridium perfringens epsilon toxin.
    Savva CG; Clark AR; Naylor CE; Popoff MR; Moss DS; Basak AK; Titball RW; Bokori-Brown M
    Nat Commun; 2019 Jun; 10(1):2641. PubMed ID: 31201325
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Morcrette H; Bokori-Brown M; Ong S; Bennett L; Wren BW; Lewis N; Titball RW
    NPJ Vaccines; 2019; 4():32. PubMed ID: 31372245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and immunological characterization of an inactivated canine Clostridium perfringens type A vaccine.
    Xing J; Ji X; Sun Y; Zhu L; Jiang Q; Guo X; Liu J
    Lett Appl Microbiol; 2019 Nov; 69(5):385-390. PubMed ID: 31529707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and Comparison of Clostridium Epsilon-Alpha Fusion Gene Expression Using Different Commercial Expression Vector.
    Sepehrifar HR; Pilehchian Langroudi R; Ataei S; Haddadi A
    Arch Razi Inst; 2021 Mar; 76(1):7-16. PubMed ID: 33818953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Mutants of Epsilon Toxin from
    Dorca-Arévalo J; Gómez de Aranda I; Blasi J
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epsilon toxin from Clostridium perfringens induces toxic effects on skin tissues and HaCaT and human epidermal keratinocytes.
    Geng Z; Kang L; Huang J; Gao S; Wang J; Yuan Y; Li Y; Wang J; Xin W
    Toxicon; 2021 Jul; 198():102-110. PubMed ID: 33965432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases.
    Huang J; Zhao B; Liu T; Kang L; Li J; Guo Z; Chen M; Gao S; Wang J; Li Y; Wang J; Xin W
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of recombinant bivalent fusion protein r-Cpib for immunotherapy against Clostridium perfringens beta and iota toxemia.
    Das S; Majumder S; Kingston JJ; Batra HV
    Mol Immunol; 2016 Feb; 70():140-8. PubMed ID: 26774054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epsilon toxin: a fascinating pore-forming toxin.
    Popoff MR
    FEBS J; 2011 Dec; 278(23):4602-15. PubMed ID: 21535407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
    Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
    Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA Nanoparticle-Based Dissolving Microneedle Vaccine of
    Wan W; Li Y; Wang J; Jin Z; Xin W; Kang L; Wang J; Li X; Cao Y; Yang H; Wang J; Gao S
    Toxins (Basel); 2023 Jul; 15(7):. PubMed ID: 37505730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cloning and expression of epsilon toxin from Clostridium perfringens type D and tests of animal immunization.
    Souza AM; Reis JK; Assis RA; Horta CC; Siqueira FF; Facchin S; Alvarenga ER; Castro CS; Salvarani FM; Silva RO; Pires PS; Contigli C; Lobato FC; Kalapothakis E
    Genet Mol Res; 2010 Feb; 9(1):266-76. PubMed ID: 20198582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of a recombinant Lactobacillus casei, surface-expressed H
    Alimolaei M; Golchin M; Baluch-Akbari A
    Toxicon; 2021 Sep; 200():173-179. PubMed ID: 34324946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement over 1 Year of Neutralizing Antibodies in Cattle Immunized with Trivalent Vaccines Recombinant Alpha, Beta and Epsilon of
    Galvão CC; Barbosa JD; Oliveira CMC; Otaka DY; Silva PRO; Ferreira MRA; Moreira Júnior C; Conceição FR; Salvarani FM
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.